Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Alemtuzumab ttCD52.php on line 2
Alemtuzumab ttCD52
LE WE PMID CA
Alemtuzumab ttCD5210565Alemtuzumab ttCD52

81C6 ttTenascin

Abatacept ttCTLA4Conjugate

Abciximab ttGPIIAIIIB

Adalimumab ttTNFalpha

AIN457

Alemtuzumab ttCD52

AMG386 ttAngiopoietin1 ttAngiopoietin2

Antibodies (therapeutic use)

Atacicept ttBlys ttAPRIL

Bapineuzumab ttAmyloidBeta

Basiliximab ttIL2R

Belatacept ttCD80 ttCD86

Belimumab ttBLyS

Bevacizumab ttVEGF

Blinatumomab ttCD19

Brentuximab vedotin ttCD30

Briakinumab ttIL12 ttIL23

Canakinumab ttIL1beta

Catumaxomab ttEpCAM ttCD3 linkerAb

CD19

CD20

CD37

Certolizumab ttTNFalpha

Cetuximab ttEGFR

Cladribine

Daclizumab ttIL2R

Dalotuzumab ttIGF1R

Denosumab ttRANKL

Eculizumab ttFactorH

Efalizumab ttLFA1

Epratuzumab ttCD22

Etanercept ttTNFalpha

FactorIXFc ttFactorIX

FactorVIIIFc ttFactorVIII

Farletuzumab ttFolateRalpha

Figitumumab ttIGF1R

Fingolimod

Flavopiridole

Fumarate

GA101 ttCD20

Galiximab ttCD80

Gemtuzumab ozogamicin ttCD33

Girentuximab ttCarbonicAnhydraseIX

Golimumab ttTNFalpha

Ibritumomab tiuxentan yttrium ttCD20

Infliximab ttTNFalpha

Inotuzumab ozogamicin ttCD22

Ipilimumab ttCTLA4

Laquinimod

Leukemia (chronic lymphatic)

Lumiliximab ttCD23

Mepolizumab ttIL5

Motavizumab ttRSVirus

Multiple sclerosis

MuromonabCD3 ttCD3

Naptumomab estafenatox tt5T4

Natalizumab ttIntegrinalpha4

Necitumumab ttEGFR

Nimotuzumab ttEGFR

Obinutuzumab ttCD20

Ocrelizumab ttCD20

Ofatumumab ttCD20

Omalizumab ttCD20

Otelixizumab ttCD3

Pagibaximab ttLipoteichoicAcidStaphlococcus

Palivizumab ttRSVirusFprotein

Panitumomab ttEGFR

Pertuzumab ttHER2

Ramucirumab ttVEGFR2

Ranibizumab ttVEGF

Raxibacumab ttAnthrax

REGN88 ttIL6R

Reslizumab ttIL5

Rilonacept ttIL1R

Rituximab ttCD20

Solanezumab ttAmyloidBeta

T1H ttCD6

Tanezumab ttNGF

Teplizumab ttCD3

Teriflunomide

Tocilizumab ttIL6

Tositumomab ttCD20

Trastuzumab emtansine ttHER2

Trastuzumab ttHER2

Tremelimumab ttCLTA4

TRU016 ttCD37

Ustekinumab ttIL12 ttIL23

Vedolizumab ttIntegrina4b7

Zalutumumab ttEGFR

Zanulimumab ttCD4

2010  
1
Refractory chronic lymphocytic leukemia--new therapeutic strategies.
[21317446] Oncotarget 1(7): 472-82 (2010)
2010  
2
New approaches in the management of multiple sclerosis.
[21151622] Drug Des Devel Ther 4(-): 343-66 (2010)
2011  
3
Antibody-based therapeutics to watch in 2011.
[21051951] MAbs 3(1): 76-99 (2011)
2010  
4
Antibodies to watch in 2010.
[20065640] MAbs 2(1): 84-100 (2010)
2007  
5
Alemtuzumab in chronic lymphocytic leukemia.
[17593982] Curr Oncol 14(3): 96-109 (2007)
2008  
6
Antibody therapy for chronic lymphocytic leukemia.
[18381104] Semin Hematol 45(2): 95-103 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Alemtuzumab ttCD52.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Alemtuzumab ttCD52.php on line 92